Interacting Drugs |
Butalbital compound and codeine vs Thrombolytic Agents |
Security Level |
 |
Mechanism |
Thrombolytic Agents: Salicylates may enhance the adverse/toxic effect of Thrombolytic Agents. An increased risk of bleeding may occur. |
Management |
Monitor therapy |
Butalbital compound and codeine vs Thrombolytic Agents
Post Review about Butalbital compound and codeine vs Thrombolytic Agents Click here to cancel reply.
Other Interactions of Butalbital compound and codeine
Other Interactions of Thrombolytic Agents
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.